Ascent Group LLC Has $4.98 Million Position in UnitedHealth Group Incorporated $UNH

Ascent Group LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 39.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,950 shares of the healthcare conglomerate’s stock after selling 10,585 shares during the period. Ascent Group LLC’s holdings in UnitedHealth Group were worth $4,976,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of UNH. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. National Bank of Canada FI boosted its stake in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.8%

UNH opened at $360.17 on Friday. The company has a fifty day moving average price of $307.84 and a 200-day moving average price of $355.58. The firm has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the firm posted $6.80 earnings per share. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

Analysts Set New Price Targets

Several equities analysts have commented on UNH shares. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Barclays lifted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Bank of America lifted their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Finally, Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.